TruAlt Bioenergy Share Price Target 2027, 2028 and 2030: Long Term Analyst Forecast

TruAlt Bioenergy at Rs 478.5 is a energy and power company whose share price target of Rs 595 for 2027 represents approximately 39 percent upside from the current market price. The TruAlt Bioenergy share price target rises to Rs 700 by 2028 and Rs 975 by 2030, implying a 4-year upside of approximately 128 percent from August 2026 levels. FY26 EPS of ₹21.0 growing approximately18% a year, capitalised at approximately24x forward earnings; growth tapers to approximately14% further out..

The targets are derived from the analyst consensus and forward earnings model based on FY26 financials. This article covers the TruAlt Bioenergy share price target 2027, 2028, and 2030 as of August 2026 to help investors evaluate the long-term investment case.

Click Here – Get Free Investment Predictions

TruAlt Bioenergy Company Overview

Metric	Details
NSE Ticker	TRUALT
Sector	Energy and Power
CMP (10 Aug 2026)	Rs 478.5
Market Cap	Rs 3670 Cr
FY26 EPS	Rs 21.0 (18% annual growth)
TruAlt Bioenergy Share Price Target 2027	Rs 595 (+39%)
TruAlt Bioenergy Share Price Target 2028	Rs 700 (+64%)
TruAlt Bioenergy Share Price Target 2030	Rs 975 (+128%)
Bull Case 2030	Rs 1,248
Bear Case 2030	Rs 731

What most investors miss: Promoters have pledged 36.8% of their holding despite very high promoter stake (88.2%) – a notable pledge risk flag; recently listed (Oct 2025 IPO)

FY26 EPS of ₹21. 0 growing approximately18% a year, capitalised at approximately24x forward earnings; growth tapers to approximately14% further out. The share price target of Rs 595 for 2027 and Rs 975 for 2030 reflect this earnings trajectory.

Why Is the TruAlt Bioenergy Share Price Target Set at Rs 595 for 2027

Operational Capacity and Plant Load Factor

This is the primary driver of the TruAlt Bioenergy share price target for 2027 and 2030. FY26 EPS of ₹21.0 growing approximately18% a year, capitalised at approximately24x forward earnings; growth tapers to approximately14% further out.. Investors tracking this metric quarterly will have the earliest signal of whether the TruAlt Bioenergy share price target timeline is on track.

Fuel Security and Input Cost Management

The TruAlt Bioenergy share price target of Rs 595 for 2027, rising to Rs 975 by 2030, assumes this factor remains intact and compounds through the forecast period. Any deterioration in this dimension would be the earliest warning for the TruAlt Bioenergy share price target thesis.

India's Power Demand Growth Is a Multi-Decade Tailwind

This structural factor underpins the long-term TruAlt Bioenergy share price target of Rs 975 by 2030 beyond the near-term 2027 milestone. Its persistence through economic cycles is what differentiates this investment from a purely cyclical trading position.

Regulatory Framework and Long-Term PPA Visibility

For the TruAlt Bioenergy share price target to materialise, this factor must continue to hold and improve through FY27 to FY31. It provides the margin of safety for the Rs 700 target in 2028 when earnings quality is most clearly visible.

Expansion Capex and New Capacity Addition Pipeline

India's long-term economic growth trajectory creates a secular tailwind for TruAlt Bioenergy's business that amplifies the company-specific earnings compounding embedded in the TruAlt Bioenergy share price target 2030 of Rs 975 (+128% from CMP Rs 478.5).

TruAlt Bioenergy Share Price Targets 2027, 2028 and 2030

TruAlt Bioenergy Share Price Target 2027: Rs 595

The TruAlt Bioenergy share price target 2027 is Rs 595, representing approximately 39 percent upside from CMP Rs 478.5. FY26 EPS of ₹21.0 growing approximately18% a year, capitalised at approximately24x forward earnings; growth tapers to approximately14% further out.. The primary catalyst for achieving the 2027 target is consistent quarterly earnings delivery that validates the analyst model underpinning the TruAlt Bioenergy share price target.

TruAlt Bioenergy Share Price Target 2028: Rs 700

The TruAlt Bioenergy share price target 2028 is Rs 700, implying approximately 64 percent upside from CMP. By FY29, TruAlt Bioenergy should have demonstrated through a complete earnings cycle that the forward growth assumptions are sustainable. This two-year validation of the TruAlt Bioenergy share price target thesis typically triggers institutional re-rating toward the Rs 700 level.

TruAlt Bioenergy Share Price Target 2030: Rs 975

The TruAlt Bioenergy share price target 2030 is Rs 975, implying approximately 128 percent upside from CMP and a 4-year CAGR of approximately 19 percent. By FY31, TruAlt Bioenergy should be operating as a mature business with a track record of consistent compounding, justifying the target multiple. Always verify data at NSE and BSE before acting on analyst price targets.

Bull Case and Bear Case for TruAlt Bioenergy Share Price Target 2030

Bull Case: Rs 1,248

The bull case TruAlt Bioenergy share price target of Rs 1,248 by 2030 requires earnings growth to exceed the base case projection and the market to re-rate the stock to a higher-than-consensus multiple. Favourable macro conditions, new product or geographic expansion wins, and sustained margin improvement would drive this upside scenario.

Bear Case: Rs 731

The bear case TruAlt Bioenergy share price target of Rs 731 by 2030 applies if earnings growth disappoints relative to analyst expectations, competitive pressure intensifies, or a macro slowdown compresses the sector multiple. Even in this scenario, the downside reflects a more conservative earnings assumption rather than a fundamental business failure.

Scenario	Target 2030	Return
Bull Case	Rs 1,248	+161%
Base Case	Rs 975	+128%
Bear Case	Rs 731	+53%

Key Risks to the TruAlt Bioenergy Share Price Target

Earnings Growth Deceleration

Any slowdown in TruAlt Bioenergy's core earnings growth below the projected rate would trigger a PE de-rating and delay the TruAlt Bioenergy share price target timeline.

Macro and Sector Headwinds

Global or Indian economic slowdown, regulatory changes, or commodity price cycles could negatively impact TruAlt Bioenergy's revenues and the TruAlt Bioenergy share price target.

Competition and Market Share Pressure

Competitive intensity from existing players or new entrants could force TruAlt Bioenergy to reduce prices or increase spending, compressing the TruAlt Bioenergy share price target margins.

Premium Valuation Risk

If the current PE multiple is not supported by sustained earnings delivery, a de-rating could set back the TruAlt Bioenergy share price target timeline materially.

How to Invest in TruAlt Bioenergy

Use the Univest Screener to track TruAlt Bioenergy's quarterly earnings, key sector-specific metrics, and analyst upgrades in real time. To purchase shares, open a demat account with any SEBI-registered broker and search for NSE ticker TRUALT. Review the quarterly earnings data and the risk factors outlined in this article before committing capital. Build positions gradually and align the holding period to the TruAlt Bioenergy share price target 2030 timeline of approximately 4 years. Consult a SEBI-registered financial advisor before investing.

Use the Univest Screener to Track This Stock Live

Conclusion

The TruAlt Bioenergy share price target of Rs 595 for 2027, Rs 700 for 2028, and Rs 975 for 2030 reflects analyst consensus earnings compounding in the energy and power sector. The 4-year upside of approximately 128 percent from CMP Rs 478.5 assumes the business delivers on the growth drivers outlined above and maintains the valuation multiple consistent with sector peers. Always verify financial data at NSE India and BSE before making any investment decision.

Download the Univest iOS App or Univest Android App to track TruAlt Bioenergy share price live and get daily stock recommendations.

Frequently Asked Questions on TruAlt Bioenergy Share Price Target 2027 2028 and 2030

What is the TruAlt Bioenergy share price target for 2027?

Ans. The TruAlt Bioenergy share price target for 2027 is Rs 595, representing approximately 39 percent upside from CMP Rs 478.5 as of August 2026. Please verify all data at NSE India before investing.

What is the TruAlt Bioenergy share price target for 2030?

Ans. The TruAlt Bioenergy share price target for 2030 is Rs 975, implying approximately 128 percent upside from CMP Rs 478.5. This reflects the analyst consensus extrapolated at the projected growth rate. These are estimates, not guaranteed returns.

What is the TruAlt Bioenergy share price target for 2028?

Ans. The TruAlt Bioenergy share price target for 2028 is Rs 700, implying approximately 64 percent upside from CMP. By 2028, two full years of earnings delivery should validate the analyst model and support a re-rating toward this level.

Is TruAlt Bioenergy a good long-term investment?

Ans. TruAlt Bioenergy has a defined analyst projection for earnings compounding through FY31 in the energy and power sector. Whether it suits your portfolio depends on your risk appetite, investment horizon, and sector allocation. Consult a SEBI-registered financial advisor before investing.

What are the key risks to the TruAlt Bioenergy share price target?

Ans. Key risks include sector-specific headwinds such as earnings growth deceleration, macro and sector headwinds, and broader macro slowdowns. Please review the full risks section in this article before investing.

What is the bull case for TruAlt Bioenergy share price by 2030?

Ans. The bull case TruAlt Bioenergy share price target for 2030 is Rs 1,248, requiring earnings growth above the base case and a higher PE multiple. This scenario needs favourable execution and sector conditions. These are analyst projections, not guaranteed returns.

What is TruAlt Bioenergy's current market cap?

Ans. TruAlt Bioenergy has a market cap of approximately Rs 3670 crore as of August 2026 based on the data available. Verify the current market cap at NSE India or BSE before making investment decisions.

How can I invest in TruAlt Bioenergy?

Ans. You can buy TruAlt Bioenergy shares through any SEBI-registered broker by searching for NSE ticker TRUALT. Review the fundamentals and risk factors before investing, and consult a SEBI-registered financial advisor for personalised guidance.